click on the image above to watch the webcast
(to view the webcast in fullscreen, click on the bottom right square icon underneath the YouTube logo)
​**Due to technical problems during recording parts of the video may have no audio**

Dr. Jesus F. San-Miguel discusses the advances in the optimal choice of therapeutic strategies for patients with relapsed/refractory disease during the Friday Satellite Symposium preceding the 60th ASH Annual Meeting & Exposition.

This video is the fourth in a five-part series that focuses on new strategies for multiple myeloma care. It was presented during the Friday Satellite Symposium preceding the 60th ASH Annual Meeting & Exposition in San Diego, CA.

click here to download slides

Other Topics:


Go Online for More Educational Programs on Myeloma!

Interactive Decision Support Tool for myeloma, with personalized expert recommendations for your patients with myeloma

Online programs on caring for your patients with myeloma


Jointly provided by the Annenberg Center for Health Sciences at Eisenhower, International Myeloma Foundation, and Clinical Care Options, LLC

This activity is supported by educational grants from AbbVie; Amgen; Bristol-Myers Squibb; Celgene Corporation; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Oncology.

 

Previous Post
Recent data on transplantation, consolidation, and maintenance after induction therapy
Next Post
Proposed 2019 treatment algorithms for Multiple Myeloma

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt out, click for more information.